Symposium

Counterfeit Pharmaceuticals

This symposium will cover the intellectual property and public health issues raised by counterfeit drugs. There are a number of international problems in this area, and each year more and more adulterated or fake medications enter the United States. Pharmaceutical companies are spending vast sums of money to combat counterfeit medications and educate the public. In fact, there have been reports that the packaging of some of these counterfeit imports are so similar to the real packaging that the only way to tell whether the drugs are real is to physically test them. There have even been deaths and serious injuries throughout the United States as a result of these fake drugs.

Counterfeit drugs also raise many other intellectual property and human health issues that we would like to bring to the forefront of academic debate.

Schedule

8:15 - 8:45 a.m.Registration
8:45 - 9:15 a.m.Breakfast/Socializing
9:15 - 9:30 a.m.Welcoming Remarks and Introduction of Speakers
9:30 - 10:45 a.m.Professor Bryan A. Liang
10:45 - 11:00 a.m.Break
11:00 - 12:00 p.m.William K. Hubbard - Former Senior Associate Commissioner for Policy, Planning, and Legislation of the FDA
12:00 - 1:30 p.m.Lunch Buffet
1:30 - 2:00p.m.Jake Wharton - Associate at Womble Carlyle
2:00 - 3:00 p.m.Professor Sandra Rierson
3:00 - 3:15 p.m.Break
3:15 - 4:15 p.m.James Thomas - Partner at Troutman Sanders and Former Vice-President and Trademark Counsel for GlaxoSmithKline
4:15 - 5:15 p.m.Panel Discussion; Q & A

Symposium Information